Vericel Corporation (VCEL) vs Vera Therapeutics, Inc. (VERA)
- Vericel Corporation VCEL 40.13 −2.17%
- Vera Therapeutics, Inc. VERA 27.88 −2.42%
Vericel Corporation and Vera Therapeutics, Inc. are both Biotechnology companies. Vericel Corporation and Vera Therapeutics, Inc. are of similar size ($2.1B and $2.1B). Vera Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 83.6×. Vericel Corporation has the higher net margin (7.91% vs 0.00%) and the higher return on invested capital (5.49% vs 0.00%). Across the 15 metrics below, Vericel Corporation leads on 13 and Vera Therapeutics, Inc. on 2.
Valuation
Profitability
| Metric | VCEL | VERA | Biotechnology median |
|---|---|---|---|
| Gross margin | 74.56% | 0.00% | 65.16% |
| Operating margin | 5.95% | 0.00% | 0.00% |
| Net margin | 7.91% | 0.00% | 0.00% |
| Free cash flow margin | 20.13% | 0.00% | 0.00% |
| Return on equity | 7.16% | (91.75%) | (56.36%) |
| Return on assets | 5.16% | (72.32%) | (48.04%) |
| Return on invested capital | 5.49% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack